Gene · 3624
Papers2,354
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,354
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An epithelial mesenchymal transition associated gene signature stratifies risk of ulcerative colitis associated colorectal cancer. | Discov Oncol | 2026 | 42319552 | PubTator, text mining | PubMed |
| Screening Biomarkers Related to Circadian Rhythm of Gastric Cancer Through Bioinformatics. | Appl Biochem Biotechnol | 2026 | 42287537 | PubTator, text mining | PubMed |
| Extracellular matrix microarchitecture modulates cellular behavior and extracellular vesicle phenotypes in biomimetic tendon models. | Bioeng Transl Med | 2026 | 42272973 | PubTator, text mining | PubMed |
| Targeted delivery of TGF-β inhibitor via LHRH-NanoTi reverses the NAT10/ac4C-mediated cisplatin-induced immunosuppressive tumor microenvironment in ovarian cancer. | J Nanobiotechnology | 2026 | 42243969 | PubTator, text mining | PubMed |
| Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival. | Gynecol Oncol | 2026 | 42176362 | PubTator, text mining | PubMed |
| Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma. | J Immunother Cancer | 2026 | 42161402 | PubTator, text mining | PubMed |
| A bioinformatics and experimental approach identifies glycoprotein-based diagnostic and prognostic biomarkers for colon adenocarcinoma. | Sci Rep | 2026 | 42151258 | PubTator, text mining | PubMed |
| A multi-omics dissection of INHBA+ CAF-mediated epithelial-mesenchymal transition and immune suppression in colorectal cancer. | J Transl Med | 2026 | 42143353 | PubTator, text mining | PubMed |
| Periodontitis induces skeletal muscle atrophy by increasing circulating levels of activin A. | Nat Commun | 2026 | 42091891 | PubTator, text mining | PubMed |
| LyP vs advanced-stage CTCLs: single-cell profiling reveals markers of self-limited vs aggressive disease behavior. | Blood Adv | 2026 | 42085604 | PubTator, text mining | PubMed |
| A Multigene Signature for Prognostic Stratification of Nasopharyngeal Carcinoma. | Cancers (Basel) | 2026 | 42073524 | PubTator, text mining | PubMed |
| Multiomics Analysis Reveals Stromal Cell State Changes and INHBA-Associated Remodeling in Calcific Aortic Valve Disease. | Arterioscler Thromb Vasc Biol | 2026 | 42059080 | PubTator, text mining | PubMed |
| Systems toxicology unravels multi-tiered carcinogenic networks of zearalenone in gastric cancer. | Front Oncol | 2026 | 41988128 | PubTator, text mining | PubMed |
| Mechanistic studies of molecular networks associated with pulmonary hypertension explored by combined transcriptome analysis of Project-methylation. | Clin Epigenetics | 2026 | 41965721 | PubTator, text mining | PubMed |
| Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC. | Sci Adv | 2026 | 41931605 | PubTator, text mining | PubMed |
| Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer. | J Cell Mol Med | 2026 | 41923561 | PubTator, text mining | PubMed |
| BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium. | Cells | 2026 | 41892283 | PubTator, text mining | PubMed |
| Two Highly Specific Mouse Monoclonal Antibodies to the Putative C-Telopeptide of Human Collagen XIα1, a Cancer Biomarker. | Antibodies (Basel) | 2026 | 41874026 | PubTator, text mining | PubMed |
| Global molecular landscape of early MASLD progression in human obesity. | Elife | 2026 | 41870035 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals heterogeneity and immune microenvironment in lymphatic metastasis of head and neck squamous cell carcinoma. | Genes Immun | 2026 | 41839993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3624/papers?page=2